🔎 Trials Near Me

Utama › Melanoma › Illinois › Chicago

Kajian klinikal Melanoma di Chicago, IL

15 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • dan 1 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • University of Illinois Cancer Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Mengambil pesertaFasa 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05136196

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Mengambil pesertaFasa 3
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
Umur 75 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07068074

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Mengambil pesertaFasa 1/2
  • Northwestern University, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • dan 1 lagi
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Mengambil peserta
  • Northwestern University, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT07556380

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Mengambil pesertaFasa 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Semua jantina · Dikemas kini 6 Jul 2026 · NCT02332668

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Mengambil pesertaFasa 1/2
  • University of Chicago Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Mengambil pesertaFasa 2/3
  • Northwestern Memorial Hospital, Chicago
  • University of Chicago Medical Center, Chicago
Semua umur · Semua jantina · Dikemas kini 2 Apr 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Chicago
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • Advocate Illinois Masonic Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Melanoma di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.